Institutional Ownership Neurosense Therapeutics LTD Wt (NRSNW)
This table provides information about the institutional ownership of Neurosense Therapeutics LTD Wt (NRSNW). We have compiled data on the 4 institutions that hold shares in the stock, with a total of 225,155 shares, which have been reported (via 13F filing form) to have a value of $119,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Empery Asset Management, LP
New York, NY |
Nov 14, 2022 Q3 2022 |
160,000
shares
|
$84,800
0.28% of portfolio
|
Q4 2021
New holding
|
|
|
Clear Street LLC
|
Aug 13, 2025 Q2 2025 |
63,685
shares
|
$33,753
0.0% of portfolio
|
Q2 2025
Reduced 3.15%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
1,470
shares
|
$779
0.0% of portfolio
|
Q2 2025
Reduced 48.26%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|